NEW YORK TIMES CO-A (NYT)

US6501111073 - Common Stock

46.6  +0.35 (+0.76%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to NYT. NYT was compared to 96 industry peers in the Media industry. NYT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NYT is valied quite expensively at the moment, while it does show a decent growth rate. This makes NYT very considerable for quality investing!



8

1. Profitability

1.1 Basic Checks

In the past year NYT was profitable.
In the past year NYT had a positive cash flow from operations.
NYT had positive earnings in each of the past 5 years.
Each year in the past 5 years NYT had a positive operating cash flow.

1.2 Ratios

NYT's Return On Assets of 9.38% is amongst the best of the industry. NYT outperforms 91.58% of its industry peers.
NYT's Return On Equity of 14.45% is amongst the best of the industry. NYT outperforms 84.21% of its industry peers.
NYT has a better Return On Invested Capital (12.01%) than 89.47% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NYT is above the industry average of 7.48%.
The 3 year average ROIC (10.37%) for NYT is below the current ROIC(12.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.38%
ROE 14.45%
ROIC 12.01%
ROA(3y)8%
ROA(5y)7.01%
ROE(3y)12.79%
ROE(5y)11.57%
ROIC(3y)10.37%
ROIC(5y)9.39%

1.3 Margins

With an excellent Profit Margin value of 8.53%, NYT belongs to the best of the industry, outperforming 82.11% of the companies in the same industry.
In the last couple of years the Profit Margin of NYT has grown nicely.
Looking at the Operating Margin, with a value of 11.23%, NYT is in the better half of the industry, outperforming 72.63% of the companies in the same industry.
NYT's Operating Margin has improved in the last couple of years.
NYT has a Gross Margin of 47.91%. This is comparable to the rest of the industry: NYT outperforms 58.95% of its industry peers.
NYT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.23%
PM (TTM) 8.53%
GM 47.91%
OM growth 3Y6.86%
OM growth 5Y2.17%
PM growth 3Y19.5%
PM growth 5Y5.91%
GM growth 3Y1.67%
GM growth 5Y-4.97%

8

2. Health

2.1 Basic Checks

NYT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, NYT has less shares outstanding
The number of shares outstanding for NYT has been reduced compared to 5 years ago.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

NYT has an Altman-Z score of 7.47. This indicates that NYT is financially healthy and has little risk of bankruptcy at the moment.
NYT's Altman-Z score of 7.47 is amongst the best of the industry. NYT outperforms 91.58% of its industry peers.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.47
ROIC/WACC1.32
WACC9.13%

2.3 Liquidity

A Current Ratio of 1.28 indicates that NYT should not have too much problems paying its short term obligations.
The Current ratio of NYT (1.28) is worse than 69.47% of its industry peers.
NYT has a Quick Ratio of 1.28. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NYT (1.28) is worse than 67.37% of its industry peers.
NYT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.33% over the past year.
Measured over the past years, NYT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.15% on average per year.
NYT shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.40%.
Measured over the past years, NYT shows a small growth in Revenue. The Revenue has been growing by 6.77% on average per year.
EPS 1Y (TTM)33.33%
EPS 3Y19.13%
EPS 5Y15.15%
EPS growth Q2Q18.64%
Revenue 1Y (TTM)29.4%
Revenue growth 3Y10.8%
Revenue growth 5Y6.77%
Revenue growth Q2Q1.3%

3.2 Future

NYT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.32% yearly.
Based on estimates for the next years, NYT will show a small growth in Revenue. The Revenue will grow by 5.15% on average per year.
EPS Next Y3.09%
EPS Next 2Y7.11%
EPS Next 3Y9.32%
EPS Next 5Y10.32%
Revenue Next Year5.18%
Revenue Next 2Y5.38%
Revenue Next 3Y5.58%
Revenue Next 5Y5.15%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.41, the valuation of NYT can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of NYT is on the same level as its industry peers.
When comparing the Price/Earnings ratio of NYT to the average of the S&P500 Index (28.11), we can say NYT is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 27.56, the valuation of NYT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NYT is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 20.39. NYT is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 28.41
Fwd PE 27.56

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NYT.
NYT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 22.68
EV/EBITDA 16.59

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NYT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of NYT may justify a higher PE ratio.
PEG (NY)9.18
PEG (5Y)1.88
EPS Next 2Y7.11%
EPS Next 3Y9.32%

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.17%.
NYT's Dividend Yield is a higher than the industry average which is at 4.23.
Compared to an average S&P500 Dividend Yield of 2.40, NYT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

The dividend of NYT is nicely growing with an annual growth rate of 21.18%!
NYT has paid a dividend for at least 10 years, which is a reliable track record.
NYT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.18%
Div Incr Years5
Div Non Decr Years10

5.3 Sustainability

NYT pays out 27.27% of its income as dividend. This is a sustainable payout ratio.
NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.27%
EPS Next 2Y7.11%
EPS Next 3Y9.32%

NEW YORK TIMES CO-A

NYSE:NYT (5/8/2024, 9:20:06 AM)

46.6

+0.35 (+0.76%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.66B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 28.41
Fwd PE 27.56
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)9.18
PEG (5Y)1.88
Profitability
Industry RankSector Rank
ROA 9.38%
ROE 14.45%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.23%
PM (TTM) 8.53%
GM 47.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)33.33%
EPS 3Y19.13%
EPS 5Y
EPS growth Q2Q
EPS Next Y3.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)29.4%
Revenue growth 3Y10.8%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y